“Faces of COPD Mosaic” Encourages Dialogue on World COPD Day

Chronic Obstructive Pulmonary Disease (COPD) Awareness Month takes place every November and marks an important time for the COPD community to come together and spark conversations about this debilitating disease that affects approximately 300 million people globally.

In recognition of this important observance, AstraZeneca has collaborated with the COPD Foundation to unveil theFaces of COPD Mosaic, a nationwide photo initiative to raise awareness of COPD and those living with the disease through the collection of individual photos.

Throughout November, the COPD Foundation and AstraZeneca engaged with the COPD patient community to develop the photo mosaic, comprised of individual photos of patients living with this disease, representing the more than 14 million American adults identified as having COPD in 2010. Another estimated 12 million people in the U.S. undiagnosed due to a variety of reasons that could include not understanding or recognizing their COPD symptoms, or not discussing these symptoms with their doctor.

Many are unaware that COPD is an umbrella term used to describe chronic lung diseases like emphysema and chronic bronchitis, two serious conditions that should not be overlooked.

The completed mosaic is now live on the Foundation’s website and on display in physician offices throughout the country, commemorating today as World COPD Day and encouraging patients with COPD to take proactive steps in talking with their doctor on how to manage their symptoms.

“The COPD Foundation remains committed to improving the quality of life of those impacted by COPD, through research and disease education,” said John Walsh, President and Co-founder of the COPD Foundation. “We are thrilled to share the results of our collaboration with AstraZeneca around this patient centric initiative. Together, we hope to inspire people living with COPD to take action to improve their respiratory health.”

Take a moment to watch this testimonial video of COPD patient Sandi, one of the many faces of COPD

AstraZeneca has a longstanding commitment to respiratory patients and we appreciate the opportunity to bring a face to the patients living with this disease through the launch of the Faces of COPD Mosaic. To continue the conversation around COPD, connect with those affected by the disease and access resources and disease education material, please visit the COPD Foundation’s online community: COPD360social.org.